These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 22663995)
1. The role of splenectomy in the setting of refractory humoral rejection after kidney transplantation. Tzvetanov I; Spaggiari M; Jeon H; Roca RG; Bhati C; Oberholzer J; Benedetti E Transplant Proc; 2012 Jun; 44(5):1254-8. PubMed ID: 22663995 [TBL] [Abstract][Full Text] [Related]
2. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983 [TBL] [Abstract][Full Text] [Related]
3. Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant. Stewart ZA; Collins TE; Schlueter AJ; Raife TI; Holanda DG; Nair R; Reed AI; Thomas CP Transplant Proc; 2012 Dec; 44(10):3033-6. PubMed ID: 23195021 [TBL] [Abstract][Full Text] [Related]
4. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614 [TBL] [Abstract][Full Text] [Related]
5. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection. Hardinger KL; Murillo D Clin Transpl; 2011; ():401-8. PubMed ID: 22755438 [TBL] [Abstract][Full Text] [Related]
6. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report. Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279 [TBL] [Abstract][Full Text] [Related]
7. The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: report of three cases and review of literature. Tzvetanov I; Spaggiari M; Joseph J; Jeon H; Thielke J; Oberholzer J; Benedetti E Transplant Proc; 2012 Dec; 44(10):2971-5. PubMed ID: 23195008 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814 [TBL] [Abstract][Full Text] [Related]
11. Successful rescue of refractory, severe antibody mediated rejection with splenectomy. Kaplan B; Gangemi A; Thielke J; Oberholzer J; Sankary H; Benedetti E Transplantation; 2007 Jan; 83(1):99-100. PubMed ID: 17220802 [TBL] [Abstract][Full Text] [Related]
12. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198 [TBL] [Abstract][Full Text] [Related]
13. High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejection. Dunn TB; Borja-Cacho D; Chinnakotla S; Finger E; Tamayo G; Verghese P; Kim Y; Manivel C; Kandaswamy R; Matas A; Pruett T; Noreen H; Krefting P; Maurer D Clin Transpl; 2011; ():381-7. PubMed ID: 22755435 [TBL] [Abstract][Full Text] [Related]
14. Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy. Yamamoto T; Kawaguchi T; Watarai Y; Tujita M; Hiramitsu T; Nanmoku K; Goto N; Katayama A; Kobayashi T; Uchida K Transplant Proc; 2012 Jan; 44(1):210-3. PubMed ID: 22310616 [TBL] [Abstract][Full Text] [Related]
15. The utilization and advantages of an exchange donor program in living donor renal transplantation: a single-center experience. Kim HS; Kwon OJ; Kang CM Transplant Proc; 2012 Jan; 44(1):14-6. PubMed ID: 22310566 [TBL] [Abstract][Full Text] [Related]
16. Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Squifflet JP; De Meyer M; Malaise J; Latinne D; Pirson Y; Alexandre GP Exp Clin Transplant; 2004 Jun; 2(1):208-13. PubMed ID: 15859930 [TBL] [Abstract][Full Text] [Related]
17. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin. Yuan XP; Wang CX; Gao W; Fu Q; He XS Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369 [TBL] [Abstract][Full Text] [Related]
18. Cell population in spleens during antibody-mediated rejection: pathologic and clinical findings. Tzvetanov I; Spaggiari M; Oberholzer J; Setty S; Stephenson A; Thielke J; West-Thielke P; Jeon H; Danielson KK; Kaplan B; Benedetti E Transplantation; 2012 Aug; 94(3):255-62. PubMed ID: 22790386 [TBL] [Abstract][Full Text] [Related]